GMP transition support for viral vector manufacture
Lead Participant:
CELL THERAPY CATAPULT LIMITED
Abstract
Awaiting Public Project Summary
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| CELL THERAPY CATAPULT LIMITED | £361,220 | £ 361,220 |
Participant |
||
| THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST |
People |
ORCID iD |
| Emma Kinsey (Project Manager) |